Bristol-Myers immunotherapy shows promise to replace chemo for melanoma

November 16, 2014 9:21 AM

2 0

(Reuters) - Chemotherapy as a treatment for advanced melanoma could soon become obsolete, researchers said on Sunday, after patients taking an experimental immuno-oncology drug from Bristol-Myers Squibb Co had a much higher survival rate and had other favorable results.

The impressive results, compared with chemo, were seen in a late-stage study of the Bristol-Myers drug Opdivo, which helps take the brakes off the immune system by blocking the protein PD-1.

Also read: China Growth Holds at 6.7%, Backed by Government and Consumers

Read more

To category page